Hydrolysis of sucrose (table sugar) into glucose and fructose is catalysed by the enzyme invertase. Glycosidases are a class of enzymes responsible for metabolising complex carbohydrates. Sucrose is a disaccharide made up of two simple sugar molecules linked together: glucose and fructose.
By hydrolyzing the glycosidic link between sucrose’s glucose and fructose, invertase makes it possible for the sugar to be broken down into its component parts. Invertase is so named because it catalyses a process known as inversion. Many organisms, including plants, fungi, and even some bacteria, have invertase and rely on it for essential metabolic functions.
Because of its unique qualities, inverted sugar is frequently used in the food sector and found in abundance in yeast. Confections, baked foods, and drinks often feature invert sugar as a sweetener. In addition to its usefulness in industry, invertase also plays a significant function in living organisms. In plants, invertase plays a role in the metabolism of sucrose, facilitating the movement of this sugar throughout the plant where it can be used for energy production or stored. Additionally, invertase has a role in the ripening of fruits and the germination of seeds.
Invertase Market Size
The global invertase market was valued at approximately USD 61.1 million in 2022, and is expected to reach approximately USD 93.7 million by 2030, expanding at a CAGR of approximately 5.5% between 2023 and 2030.
The uses for invertase extend far beyond the realm of the food and beverage industries. It finds application in drug manufacturing, drug delivery, and biotechnology. Drug synthesis and the industrial manufacturing of specialty sugars are only two examples of the many pharmaceutical and biotech uses for invertase, which hydrolyzes sucrose into glucose and fructose. Thus, the expanding use of invertase in pharma and biotech is anticipated to present a promising growth potential for the invertase market in the coming years.
The invertase market is anticipated to be largest in North America. The region’s prosperity can be traced to the thriving food and beverage and pharmaceutical industries. For instance, the Economic Research Service of the United States Department of Agriculture projects a double-digit percentage increase in 2022 in the demand for organic products among consumers. There is also a demand for organic fruit because there are about 20,000 natural food outlets in the country. Consumers are willing to pay a premium for exceptional health, despite the fact that healthy, natural, and organic produce is more expensive than conventional commodities such as carbonated soft drinks, snack meals, baked goods, staple foods, and caffeinated beverages. The GDP per person in the United States is now $16,359. This is an increase from the $2,553 recorded in 2009.
During the forecast period, Asia-Pacific is anticipated to develop at the greatest CAGR. The expansion of the pharmaceutical industry in the region is largely responsible for this. For instance, between 2008 and 2021, the pharmaceutical industry attracted the highest amount of foreign direct investment ($32 billion), significantly more than investments in the medical devices ($20 billion), biotechnology ($17 billion), and healthcare ($10.8 billion) subsectors, as reported by the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) and the Asia-Pacific Trade and Investment Trends 2022/2023.
The global invertase market is segmented as follows:
By End User
- Food & Beverages
- Personal Care
By Distribution Channel
- Convenience Store
- Direct Selling